What if we could decentralize clinical trials, so that any patient, anywhere in the world, could participate?
That’s the mission of Curebase: making effective decentralized clinical trials a reality so that more people can participate in them.
The company’s software platform and virtual staff enable clinical trial recruitment and data collection from local clinics and telehealth, to drive-through sites and pharmacies, among many other settings.
Tom Lemberg Bio: Tom is the Founder and CEO of Curebase. His mission is to disrupt and improve the slow-moving $50B clinical trials industry.
Company Website: https://www.curebase.com